Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Current Deferred Revenue (2017 - 2018)

Historic Current Deferred Revenue for Cue Biopharma (CUE) over the last 2 years, with Q4 2018 value amounting to $381465.0.

  • Cue Biopharma's Current Deferred Revenue rose 94901.83% to $381465.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $381465.0, marking a year-over-year increase of 94901.83%. This contributed to the annual value of $381465.0 for FY2018, which is 94901.83% up from last year.
  • According to the latest figures from Q4 2018, Cue Biopharma's Current Deferred Revenue is $381465.0, which was up 94901.83% from $225000.0 recorded in Q3 2018.
  • Over the past 5 years, Cue Biopharma's Current Deferred Revenue peaked at $381465.0 during Q4 2018, and registered a low of $36364.0 during Q4 2017.